142 Biotechnology issuers carry a screening verdict, out of 755 issuers we hold in this industry. Verdicts come from two independent engines and each row says which.
149 screened by our own engine against published ratio methodologies computed from primary filings · 52 carrying a reviewed third-party provider verdict.
Classified under Healthcare.
The seven standards HTR computes reach different verdicts on 94 of the 498 Biotechnology issuers that more than one of them can decide — 19%.
A split is one issuer at least one standard passes and at least one fails. Why they disagree is mostly the denominator each standard measures debt against, not the ceiling.
Compliant first, then alphabetical. Every row links to that issuer's full ratio breakdown, business-activity screen and the filing behind it.
| Issuer | Verdict | Screened | Source |
|---|---|---|---|
| MRNA Moderna Inc | NON-COMPLIANT | 2026-10-08 | provider |
| MOLN.SW Molecular Partners AG | UNRATED | 2026-08-28 | in-house |
| MOLN MOLN | NO VERDICT | — | not screened yet |
| GLUE Monte Rosa Therapeutics Inc | NON-COMPLIANT | 2026-10-08 | provider |
| MLEC Moolec Science SA | UNRATED | 2026-08-28 | in-house |
| MPLT MPLT | NO VERDICT | — | not screened yet |
| MREO MREO | NO VERDICT | — | not screened yet |
| MRKR MRKR | NO VERDICT | — | not screened yet |
| MRVI MRVI | NO VERDICT | — | not screened yet |
| MSLE MSLE | NO VERDICT | — | not screened yet |
| MTNB MTNB | NO VERDICT | — | not screened yet |
| MTVA MTVA | NO VERDICT | — | not screened yet |
| 9887.HK Nanjing Leads Biolabs Co., Ltd. | NON-COMPLIANT | 2026-08-28 | in-house |
| NAUT NAUT | NO VERDICT | — | not screened yet |
| NBRVF NBRVF | NO VERDICT | — | not screened yet |
| NCEL NCEL | NO VERDICT | — | not screened yet |
| NCNA NCNA | NO VERDICT | — | not screened yet |
| NERV NERV | NO VERDICT | — | not screened yet |
| NEUP NEUP | NO VERDICT | — | not screened yet |
| NEU.AX Neuren Pharmaceuticals Limited | NON-COMPLIANT | 2026-08-28 | in-house |
| NRSN NeuroSense Therapeutics Ltd. | UNRATED | 2026-08-28 | in-house |
| NAMS NewAmsterdam Pharma Company N.V. | UNRATED | 2026-08-28 | in-house |
| NGEN NGEN | NO VERDICT | — | not screened yet |
| NGNE NGNE | NO VERDICT | — | not screened yet |
| NIKI NIKI | NO VERDICT | — | not screened yet |
| NKTR NKTR | NO VERDICT | — | not screened yet |
| NKTX NKTX | NO VERDICT | — | not screened yet |
| NMRA NMRA | NO VERDICT | — | not screened yet |
| NNVC NNVC | NO VERDICT | — | not screened yet |
| NBP NovaBridge Biosciences | NON-COMPLIANT | 2026-08-28 | in-house |
| NRIX NRIX | NO VERDICT | — | not screened yet |
| NTHI NTHI | NO VERDICT | — | not screened yet |
| NTLA NTLA | NO VERDICT | — | not screened yet |
| NTRB NTRB | NO VERDICT | — | not screened yet |
| NUVB NUVB | NO VERDICT | — | not screened yet |
| NVAX NVAX | NO VERDICT | — | not screened yet |
| NVCT NVCT | NO VERDICT | — | not screened yet |
| 4565.T Nxera Pharma Co., Ltd. | NON-COMPLIANT | 2026-08-26 | in-house |
| NXTC NXTC | NO VERDICT | — | not screened yet |
| NYKD.OL Nykode Therapeutics AS | UNRATED | 2026-08-28 | in-house |
| NYMXF NYMXF | NO VERDICT | — | not screened yet |
| OABI OABI | NO VERDICT | — | not screened yet |
| OBIO OBIO | NO VERDICT | — | not screened yet |
| OBX OBX | NO VERDICT | — | not screened yet |
| OCEA OCEA | NO VERDICT | — | not screened yet |
| OCGN OCGN | NO VERDICT | — | not screened yet |
| OCUL OCUL | NO VERDICT | — | not screened yet |
| OCS Oculis Holding AG | UNRATED | 2026-08-28 | in-house |
| ODTX ODTX | NO VERDICT | — | not screened yet |
| OGEN OGEN | NO VERDICT | — | not screened yet |
| OKUR OKUR | NO VERDICT | — | not screened yet |
| OKYO OKYO Pharma Limited | UNRATED | 2026-08-28 | in-house |
| OLMA OLMA | NO VERDICT | — | not screened yet |
| OMER OMER | NO VERDICT | — | not screened yet |
| ONCY ONCY | NO VERDICT | — | not screened yet |
| ONWD.BR Onward Medical N.V. | NON-COMPLIANT | 2026-08-28 | in-house |
| ONWRF ONWRF | NO VERDICT | — | not screened yet |
| IRD Opus Genetics, Inc. Common Stock | NON-COMPLIANT | 2026-10-08 | provider |
| ORMP Oramed Pharmaceuticals Inc. | UNRATED | 2026-08-28 | in-house |
| ORGS ORGS | NO VERDICT | — | not screened yet |
| ORKA ORKA | NO VERDICT | — | not screened yet |
| ORY.MC Oryzon Genomics S.A. | UNRATED | 2026-08-28 | in-house |
| OSE.PA OSE Immunotherapeutics SA | NON-COMPLIANT | 2026-08-27 | in-house |
| OSTX OSTX | NO VERDICT | — | not screened yet |
| OTLC OTLC | NO VERDICT | — | not screened yet |
| OTLK OTLK | NO VERDICT | — | not screened yet |
| OVID OVID | NO VERDICT | — | not screened yet |
| ONT.L Oxford Nanopore Technologies plc | NON-COMPLIANT | 2026-08-27 | in-house |
| PALI PALI | NO VERDICT | — | not screened yet |
| PAR.AX Paradigm Biopharmaceuticals Limited | UNRATED | 2026-08-28 | in-house |
| PASG PASG | NO VERDICT | — | not screened yet |
| PBLS PBLS | NO VERDICT | — | not screened yet |
| PBM PBM | NO VERDICT | — | not screened yet |
| PCSA PCSA | NO VERDICT | — | not screened yet |
| PCVX PCVX | NO VERDICT | — | not screened yet |
| PDSB PDSB | NO VERDICT | — | not screened yet |
| PTHS Pelthos Therapeutics Inc. | NON-COMPLIANT | 2026-10-08 | provider |
| PTP.F Pentixapharm Holding AG | UNRATED | 2026-08-28 | in-house |
| PEPG PEPG | NO VERDICT | — | not screened yet |
| PFSF PFSF | NO VERDICT | — | not screened yet |
| PGEN PGEN | NO VERDICT | — | not screened yet |
| PHVS Pharvaris N.V. | UNRATED | 2026-08-28 | in-house |
| PHAT PHAT | NO VERDICT | — | not screened yet |
| PHIO PHIO | NO VERDICT | — | not screened yet |
| PKTX PKTX | NO VERDICT | — | not screened yet |
| PLRX PLRX | NO VERDICT | — | not screened yet |
| PLRZ PLRZ | NO VERDICT | — | not screened yet |
| PLUR PLUR | NO VERDICT | — | not screened yet |
| PMCB PMCB | NO VERDICT | — | not screened yet |
| PMVP PMVP | NO VERDICT | — | not screened yet |
| 6550.TW Polaris Group | NON-COMPLIANT | 2026-08-28 | in-house |
| PYPD PolyPid Ltd. | UNRATED | 2026-08-28 | in-house |
| PPBT PPBT | NO VERDICT | — | not screened yet |
| PPCB PPCB | NO VERDICT | — | not screened yet |
| PRAX PRAX | NO VERDICT | — | not screened yet |
| PRLD PRLD | NO VERDICT | — | not screened yet |
| PRME PRME | NO VERDICT | — | not screened yet |
| PRNAF PRNAF | NO VERDICT | — | not screened yet |
| PROK PROK | NO VERDICT | — | not screened yet |
| PMN ProMIS Neurosciences, Inc. | UNRATED | 2026-08-28 | in-house |